ADC Therapeutics SA (ADCT) Income Statement: Revenue & Earnings

ADC Therapeutics SA Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

ADC Therapeutics SA income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	70.84	69.56	209.91	33.92	-246.29
Cost of Revenue	115.58	2.53	189.76	1.39	141.82
Gross Profit	-44.75	67.03	20.15	32.52	-141.82
Operating Expenses
Research & Development	109.63	127.13	186.46	158.00	142.03
Selling, General & Administrative	85.91	105.89	143.49	136.24	77.23
Operating Expenses	85.91	233.02	143.49	312.58	77.23
Operating Income	-130.65	-165.99	-123.34	-280.06	-219.05
Other Income/Expense
Interest Income	12.27	10.54	2.57	0.07	0.83
Interest Expense	-50.21	-46.33	-36.73	18.34	-4.93
Other Income/Expense	12.54	-0.82	52.91	201.54	-46.40
Income
Income Before Tax	-157.68	-195.42	-156.90	-481.53	-245.96
Income Tax Expense	0.17	39.11	0.23	-21.48	0.33
Net Income	-157.85	-240.05	-157.13	-460.05	-246.29
Net Income - Continuous Operations	-157.85	-240.05	-157.13	-230.03	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-129.32	-132.15	-122.28	-481.40	-218.23
EBIT	-130.65	-154.62	-123.34	-481.53	-219.05
Depreciation & Amortization	1.33	1.19	1.06	-1.71	0.82
Earnings Per Share
Basic EPS	-2.00	-3.00	-2.00	-3.00	-4.00
Diluted EPS	-2.00	-3.00	-2.00	-3.00	-4.00
Basic Shares Outstanding	97.16	81.71	78.15	76.75	65.41
Diluted Shares Outstanding	97.16	81.71	78.15	76.75	65.41